159 related articles for article (PubMed ID: 16133866)
1. Synergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis.
Drexler HC; Euler M
Apoptosis; 2005 Aug; 10(4):743-58. PubMed ID: 16133866
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
[TBL] [Abstract][Full Text] [Related]
4. c-IAP1 blocks TNFalpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells.
Partheniou F; Kelsey SM; Srinivasula SM; Newland AC; Alnemri ES; Jia L
Biochem Biophys Res Commun; 2001 Sep; 287(1):181-9. PubMed ID: 11549272
[TBL] [Abstract][Full Text] [Related]
5. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
6. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.
Emanuele S; Lauricella M; Carlisi D; Vassallo B; D'Anneo A; Di Fazio P; Vento R; Tesoriere G
Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells.
Jun DY; Kim JS; Park HS; Song WS; Bae YS; Kim YH
Toxicol Appl Pharmacol; 2007 Jul; 222(2):190-201. PubMed ID: 17559898
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
9. Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade.
Jun DY; Kim JS; Park HS; Han CR; Fang Z; Woo MH; Rhee IK; Kim YH
Carcinogenesis; 2007 Jun; 28(6):1303-13. PubMed ID: 17301064
[TBL] [Abstract][Full Text] [Related]
10. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
[TBL] [Abstract][Full Text] [Related]
11. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
Denlinger CE; Rundall BK; Jones DR
J Thorac Cardiovasc Surg; 2004 Nov; 128(5):740-8. PubMed ID: 15514602
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart MJ; Tainton KM; Ruefli AA; Dear AE; Sedelies KA; O'Reilly LA; Waterhouse NJ; Trapani JA; Johnstone RW
Cancer Res; 2003 Aug; 63(15):4460-71. PubMed ID: 12907619
[TBL] [Abstract][Full Text] [Related]
14. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway.
Medina V; Edmonds B; Young GP; James R; Appleton S; Zalewski PD
Cancer Res; 1997 Sep; 57(17):3697-707. PubMed ID: 9288776
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes.
Kühn K; Lotz M
Arthritis Rheum; 2001 Jul; 44(7):1644-53. PubMed ID: 11465715
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.
Kumar KS; Sonnemann J; Beck JF
Oncol Rep; 2006 Nov; 16(5):1047-52. PubMed ID: 17016591
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.
Bernhard D; Skvortsov S; Tinhofer I; Hübl H; Greil R; Csordas A; Kofler R
Cell Death Differ; 2001 Oct; 8(10):1014-21. PubMed ID: 11598799
[TBL] [Abstract][Full Text] [Related]
19. Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation.
Yang Z; Gagarin D; Ramezani A; Hawley RG; McCaffrey TA
J Vasc Res; 2007; 44(6):483-94. PubMed ID: 17657164
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin.
De Schepper S; Bruwiere H; Verhulst T; Steller U; Andries L; Wouters W; Janicot M; Arts J; Van Heusden J
J Pharmacol Exp Ther; 2003 Feb; 304(2):881-8. PubMed ID: 12538846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]